A Randomised Controlled Trial to Assess Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure
试验速览
- 阶段
- 不适用
- 入组人数
- 640
- 试验地点
- 2
- 主要终点
- Virological treatment failure
研究概览
简要总结
This project aims to assess different antiretroviral treatment strategies, optimally controlled and conventional, in relation to drug resistance and virological treatment failure. A Randomised Controlled trial (RCT) where Vietnamese HIV+ patients with CD4+ T-cells <200/ul are randomized into either enhanced treatment support (ETS) through peer supporters or The National AIDS Control Program recommended self supervised treatment (SST). The treatment strategies will be assessed and compared in relation to treatment adherence and drug resistance development with virological treatment failure as primary endpoint. The results from this project will lead to an increased knowledge in relation the impact of treatment support on adherence, virological suppression and resistance development and have an impact on HIV treatment policies in low income settings globally.
详细描述
Aim To study the impact of patient support on selective drug pressure, defined by semi-quantitative assessments of adherence, on the viral suppression and resistance development through a randomised controlled trial of HIV positive patients randomised in enhanced treatment support (ETS) and self supervised treatment (SST).
Specific Objectives
- To create a study population 600 HIV+ patients with CD4+ T-cell count of <200/ul and randomize in two different treatment cohorts, enhanced treatment support (ETS) and conventional self-supervised treatment (SST).
- To monitor the patients using semi-quantitative assessments of adherence, clinical status including clinical examinations (every 3 months), viral load and CD4+ T-cell count (every 6 months) during 24 months with virological treatment failure as primary endpoint.
- To compare the ETS and SST cohorts with respect to the primary endpoint, virological treatment failure, in relation to the semi-quantitative assessments of adherence and to analyse the mechanism of selective drug pressure for the development of resistance including resistance in minor viral subpopulations.
- To conduct a cost effectiveness assessment comparing ETS and SST with respect to the labour and infrastructural cost, virological treatment failure and change to second line therapy.
The study is conducted in Quang Ninh Province, the area hardest hit by the HIV epidemic in Vietnam with a known HIV+ prevalence above 1%. A study population of 600 HIV+ patients with CD4+ T-cell count of <200 are being be recruited in four districts, Ha Long, Uong Bi, Yen Huong and Dong Trieu. Each HIV+ person is examined according to WHO guidelines. HIV+ persons receive a complete physical examination, clinical staging of HIV infection, opportunistic infections including HBV, HCV and tuberculosis. Laboratory testing will include Full blood count, CD4+ T-cell count, viral load using the affordable and simple ELISA based ExaVirR viral load test (http://www.cavidi.se), liver enzymes, PAP smear and pregnancy test for women. If indicated (e.g. prolonged cough) chest X-ray, sputum microscopy for AFB are done.
Opportunistic infections in HIV+ patients are treated according to national guidelines. HIV+ persons receive counselling including information about the disease and the plan for care and treatment, follow-up visits, nutrition and living, prevention of HIV transmission including safe sex, harm reduction measures, the use of birth control methods and prevention of mother to child HIV transmission.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 59 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •WHO stage IV of HIV disease, regardless of the CD4 count
- •WHO stage III of HIV disease with a CD4 count < 350/mm3
- •WHO stages I or II with a CD4 count < 200/mm3
排除标准
- •Pregnancy
- •Ongoing severe opportunistic infections
- •Institutionalized patients.
结局指标
主要结局
Virological treatment failure
时间窗: 24 months
HIV viral load of 1 fg reverse transcriptase activity/ml, corresponding to 200 copies/ml, at 1 year and 2 years after starting treatment.
次要结局
- Immunological treatment failure(24 months)
- Clinical treatment failure(24 months)
研究者
Mattias Larsson
MD PhD
Karolinska Institutet
